Attached files
file | filename |
---|---|
EX-3.1 - EXHIBIT 3.1 - EKSO BIONICS HOLDINGS, INC. | v403902_ex3-1.htm |
EX-23.1 - EXHIBIT 23.1 - EKSO BIONICS HOLDINGS, INC. | v403902_ex23-1.htm |
EX-31.2 - EXHIBIT 31.2 - EKSO BIONICS HOLDINGS, INC. | v403902_ex31-2.htm |
EX-32.1 - EXHIBIT 32.1 - EKSO BIONICS HOLDINGS, INC. | v403902_ex32-1.htm |
EX-31.1 - EXHIBIT 31.1 - EKSO BIONICS HOLDINGS, INC. | v403902_ex31-1.htm |
EX-10.9(B) - EXHIBIT 10.9(B) - EKSO BIONICS HOLDINGS, INC. | v403902_ex10-9b.htm |
EX-10.7(B) - EXHIBIT 10.7(B) - EKSO BIONICS HOLDINGS, INC. | v403902_ex10-7b.htm |
EX-10.32 - EXHIBIT 10.32 - EKSO BIONICS HOLDINGS, INC. | v403902_ex10-32.htm |
EX-10.6(B) - EXHIBIT 10.6(B) - EKSO BIONICS HOLDINGS, INC. | v403902_ex10-6b.htm |
EX-10.11(C) - EXHIBIT 10.11(C) - EKSO BIONICS HOLDINGS, INC. | v403902_ex10-11c.htm |
EXCEL - IDEA: XBRL DOCUMENT - EKSO BIONICS HOLDINGS, INC. | Financial_Report.xls |
10-K - FORM 10-K - EKSO BIONICS HOLDINGS, INC. | v403902_10k.htm |
Exhibit 32.2
CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350
In connection with the Annual Report on Form 10-K of Ekso Bionics Holdings, Inc. (the “Company”), for the fiscal year ended December 31, 2014 as filed with the Securities and Exchange Commission (the “Report”), I, Max Scheder-Bieschin, Chief Financial Officer and principal financial officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. |
Dated: March 19, 2015
/s/ Max Scheder-Bieschin | |
Max Scheder-Bieschin | |
Principal Financial Officer |